Wellington, NZ, October 29, 2019: Volpara Solutions, an industry leader in cancer screening workflow, today announced the expansion of its global Medical Advisory Board.
Volpara Signs Distribution Agreement to Sell Transpara™, Screenpoint Medical’s AI Solution for Breast Cancer Detection
Wellington, NZ, July 23, 2019 – Volpara Solutions and ScreenPoint Medical BV today announced signature of an agreement under which Volpara will sell ScreenPoint’s Transpara™ products to breast imaging clinics...
Breast Imaging Analytics Software Helps Breast Care Team Deliver Personalized Health with High-Quality Images
Companies Committed to Deliver Technologies Enabling Personalized Breast Care
Wellington, NZ, May 20, 2019 – Research has demonstrated that the use of Volpara Solutions’ Volpara®Density™ software in combination with the Tyrer-Cuzick Breast Cancer Risk Evaluation Tool improves breast cancer...
MDSAP Certification Satisfies ISO and Regulatory Compliance Requirements for Japan, Australia, Canada, and the United States
GE Healthcare is now a global distributor of Volpara®Density™ software
Volpara Solutions’ Quantitative Breast Imaging Tools Support 11 Breast Screening Studies Presented at ECRVIENNA, February 26, 2019 – Volpara Solutions Ltd will launch a new version of the Volpara®Live!™ system...
Volpara Solutions Launches Next-Generation VolparaDensity Software to Support Hologic’s Curved Paddles
Recent FDA Clearance Enhances Breast Density Assessment Performance and Expands the Types of Information Provided to Clinicians